首页> 外文期刊>Journal of minimally invasive gynecology >Port-site metastasis after laparoscopic surgical staging of endometrial cancer: a systematic review of the published and unpublished data.
【24h】

Port-site metastasis after laparoscopic surgical staging of endometrial cancer: a systematic review of the published and unpublished data.

机译:腹腔镜子宫内膜癌手术分期后的端口位转移:已发表和未发表数据的系统评价。

获取原文
获取原文并翻译 | 示例
       

摘要

Port-site metastases, also called trocar-site metastasis, have been described after laparoscopic surgery for non-gynecological and gynecological cancers. The aim of this review was to obtain evidence for port-site metastases after laparoscopic surgical staging of endometrial cancer. A systematic search of published and unpublished cases of port-site metastases after laparoscopic staging of endometrial cancer was conducted. All the authors responsible for correspondence were contacted to obtain any missing data. The patients' characteristics and oncologic, surgical, and safety data were recorded and analyzed. Twelve cases of port-site metastases were identified and examined. In 4 cases they were "isolated," that is, recurrence without association with peritoneal carcinomatosis, whereas in 8 cases they were "nonisolated." The port-site metastases did not occur as a result of trocar site localization or dimension. No univocal strategy to prevent port-site metastases was adopted. Among patients with nonisolated port-site metastases, an aggressive histologic condition and a high grade were found in 3 of 6 patients and in 3 of 5 patients, respectively. Among patients with isolated port-site metastases, an early-stage endometrioid adenocarcinoma G2 endometrial cancer and a stage IIB G2 endometrioid adenocarcinoma were described in 3 of 4 patients and in only 1 case, respectively. All the patients with nonisolated port-site metastases died of disease. Similarly, among patients with isolated port-site metastases, only 1 was alive and free of disease after 10 months from recurrence diagnosis. Port-site metastases of endometrial cancer are an entity rarely reported but probably the expression of an aggressive disease. The available data do not allow us to draw conclusions or suggestions for their prevention and the treatment.
机译:在非妇科和妇科癌症的腹腔镜手术后,已经描述了端口位转移,也称为套管针位转移。这项审查的目的是获得腹腔镜子宫内膜癌手术分期后的港口现场转移的证据。对腹腔镜子宫内膜癌分期后已发表和未发表的港口部位转移病例进行系统搜索。与所有负责通信的作者进行了联系,以获取所有丢失的数据。记录并分析患者的特征以及肿瘤,手术和安全性数据。确定并检查了12例港口现场转移病例。在4例中,它们是“孤立的”,即复发与腹膜癌无关,而在8例中,它们是“未孤立的”。由于套管针部位的位置或尺寸,未发生港口部位转移。没有采取明确的策略来预防港口现场转移。在非孤立的转移部位患者中,分别在6例患者中的3例和5例患者中的3例中发现了侵袭性组织学状况和高级别。在孤立的有端口转移的患者中,分别在4例患者中的3例和仅1例中描述了早期子宫内膜样腺癌G2子宫内膜癌和IIB G2期子宫内膜样腺癌。所有非孤立性端口部位转移的患者均死于疾病。同样,在患有孤立的端口部位转移的患者中,从复发诊断开始的10个月后,只有1个存活并且没有疾病。子宫内膜癌的端口转移是一个鲜有报道的实体,但可能是侵略性疾病的表达。现有数据不允许我们对它们的预防和治疗得出结论或建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号